Vellore Institute Of Head And Neck Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-06-2024
- Paid Up Capital ₹ 0.10 M
as on 16-06-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 1115.50%
(FY 2023)
- Profit -291.64%
(FY 2023)
- Ebitda -1373.89%
(FY 2023)
- Net Worth -37.69%
(FY 2023)
- Total Assets 134.78%
(FY 2023)
About Vellore Institute Of Head And Neck Sciences
The Corporate was formerly known as Vellore Institute Of Head & Neck Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kritika Butta and Jaya Butta serve as directors at the Company.
- CIN/LLPIN
U74999WB2016PTC218396
- Company No.
218396
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vellore Institute Of Head And Neck Sciences?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kritika Butta | Director | 23-Nov-2016 | Current |
Jaya Butta | Director | 23-Nov-2016 | Current |
Financial Performance of Vellore Institute Of Head And Neck Sciences.
Vellore Institute Of Head And Neck Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1115.5% increase. The company also saw a substantial fall in profitability, with a 291.64% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Vellore Institute Of Head And Neck Sciences?
In 2023, Vellore Institute Of Head And Neck Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Dental World Super Speciality Clinics Private LimitedActive 24 years 5 months
Kritika Butta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vellore Institute Of Head And Neck Sciences?
Unlock and access historical data on people associated with Vellore Institute Of Head And Neck Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vellore Institute Of Head And Neck Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vellore Institute Of Head And Neck Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.